85 related articles for article (PubMed ID: 8200844)
21. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
[TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.
Margulies BS; DeBoyace SD; Damron TA; Allen MJ
Bone; 2015 Oct; 79():121-30. PubMed ID: 26051470
[TBL] [Abstract][Full Text] [Related]
23. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
[TBL] [Abstract][Full Text] [Related]
24. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
[TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction.
Merino ME; Navid F; Christensen BL; Toretsky JA; Helman LJ; Cheung NK; Mackall CL
J Clin Oncol; 2001 Aug; 19(16):3649-59. PubMed ID: 11504746
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
[TBL] [Abstract][Full Text] [Related]
27. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
28. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
29. Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro.
Yang M; Zhang R; Yan M; Ye Z; Liang W; Luo Z
Biochem Biophys Res Commun; 2010 Jan; 391(1):1062-6. PubMed ID: 20004177
[TBL] [Abstract][Full Text] [Related]
30. Bone induction by Ewing's sarcoma. Transplantation into athymic nude mice.
Bauer FC; Mirra JM; Urist MR
Arch Pathol Lab Med; 1981 Jun; 105(6):322-4. PubMed ID: 6894528
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
32. Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.
Scotlandi K; Avnet S; Benini S; Manara MC; Serra M; Cerisano V; Perdichizzi S; Lollini PL; De Giovanni C; Landuzzi L; Picci P
Int J Cancer; 2002 Sep; 101(1):11-6. PubMed ID: 12209582
[TBL] [Abstract][Full Text] [Related]
33. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
Lu Q; Lu M; Li D; Zhang S
Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
[TBL] [Abstract][Full Text] [Related]
36. Identification of cancer stem cells in Ewing's sarcoma.
Suvà ML; Riggi N; Stehle JC; Baumer K; Tercier S; Joseph JM; Suvà D; Clément V; Provero P; Cironi L; Osterheld MC; Guillou L; Stamenkovic I
Cancer Res; 2009 Mar; 69(5):1776-81. PubMed ID: 19208848
[TBL] [Abstract][Full Text] [Related]
37. Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.
Kawaguchi K; Koike M
Am J Clin Pathol; 1986 Jul; 86(1):79-83. PubMed ID: 3088982
[TBL] [Abstract][Full Text] [Related]
38. Morphological differentiation of cultured mouse glioblastoma cells induced by dibutyryl cyclic adenosine monophosphate.
Sato S; Sugimura T; Yoda K; Fujimura S
Cancer Res; 1975 Sep; 35(9):2494-9. PubMed ID: 167961
[TBL] [Abstract][Full Text] [Related]
39. Absence of amplification of HER-2/neu (c-erbB-2) gene in Ewing's sarcoma: a real-time polymerase chain reaction method.
Kim GY; Park JH; Kim YW; Jung WW; Unni KK; Park YK
Pathol Res Pract; 2004; 200(10):663-7. PubMed ID: 15648603
[TBL] [Abstract][Full Text] [Related]
40. N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.
Dexter DL
Cancer Res; 1977 Sep; 37(9):3136-40. PubMed ID: 195720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
